论文部分内容阅读
近日,南京红太阳股份有限公司对外发布2012年年报显示,公司全年实现营业收入71.75亿元,同比增长了23.94%;归属上市公司股东的净利润2.90亿元,同比增长了322.63%。其净利润主要来自于吡啶产业链及毒死蜱产业链。目前已跻身全球最大吡啶厂商的红太阳拥有6.2万吨吡啶碱、2万吨百草枯的年产能,吡啶及其系列产品约占市场份额的50%。据悉,2012年,面对经济增速放缓、实业经济尤
Recently, Nanjing Red Sun Co., Ltd. released its 2012 annual report on external disclosure. The company realized an operating income of 7.175 billion yuan for the whole year, an increase of 23.94% over the same period of last year. The net profit attributable to shareholders of the listed company was 290 million yuan, an increase of 322.63% over the same period of last year. Its net profit mainly comes from pyridine industry chain and chlorpyrifos industry chain. Red Sun, which is currently the largest pyridine producer in the world, has an annual capacity of 62,000 tons of pyridine base and 20,000 tons of paraquat. The pyridine and its series products account for about 50% of the market share. It is reported that in 2012, faced with economic slowdown, industrial economy especially